DE69003347D1 - Elemente mit protrahierter Wirkstoffabgabe. - Google Patents

Elemente mit protrahierter Wirkstoffabgabe.

Info

Publication number
DE69003347D1
DE69003347D1 DE90311278T DE69003347T DE69003347D1 DE 69003347 D1 DE69003347 D1 DE 69003347D1 DE 90311278 T DE90311278 T DE 90311278T DE 69003347 T DE69003347 T DE 69003347T DE 69003347 D1 DE69003347 D1 DE 69003347D1
Authority
DE
Germany
Prior art keywords
elements
active ingredient
protracted release
protracted
release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE90311278T
Other languages
English (en)
Other versions
DE69003347T2 (de
Inventor
Louis Michel Jaques Aguadisch
Bernard Francis Grisoni
Alain Etienne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dow Silicones Belgium SPRL
Dow Corning France SAS
Original Assignee
Dow Corning SA
Dow Corning France SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Corning SA, Dow Corning France SAS filed Critical Dow Corning SA
Publication of DE69003347D1 publication Critical patent/DE69003347D1/de
Application granted granted Critical
Publication of DE69003347T2 publication Critical patent/DE69003347T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/2036—Silicones; Polysiloxanes

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE90311278T 1989-10-23 1990-10-16 Elemente mit protrahierter Wirkstoffabgabe. Expired - Fee Related DE69003347T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8913818A FR2653337B1 (fr) 1989-10-23 1989-10-23 Element a liberation prolongee et procede pour le fabriquer.

Publications (2)

Publication Number Publication Date
DE69003347D1 true DE69003347D1 (de) 1993-10-21
DE69003347T2 DE69003347T2 (de) 1994-02-17

Family

ID=9386646

Family Applications (1)

Application Number Title Priority Date Filing Date
DE90311278T Expired - Fee Related DE69003347T2 (de) 1989-10-23 1990-10-16 Elemente mit protrahierter Wirkstoffabgabe.

Country Status (13)

Country Link
EP (1) EP0425154B1 (de)
JP (1) JPH03167116A (de)
KR (1) KR910007518A (de)
AU (1) AU639947B2 (de)
BR (1) BR9005223A (de)
CA (1) CA2027865A1 (de)
DE (1) DE69003347T2 (de)
DK (1) DK0425154T3 (de)
ES (1) ES2044451T3 (de)
FI (1) FI905195A0 (de)
FR (1) FR2653337B1 (de)
HU (1) HUT69395A (de)
IE (1) IE66826B1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721365A (en) * 1989-09-15 1998-02-24 Us Health N-substituted piperazine NONOates
US5208233A (en) * 1989-09-15 1993-05-04 The United States Of America As Represented By The Department Of Health And Human Services Anti-hypertensive compositions of secondary amine-nitric oxide adducts and use thereof
FR2677253A1 (fr) * 1991-06-07 1992-12-11 Union Metropolitaine Pharmaceu Composition therapeutique utile vis-a-vis des maladies inflammatoires du systeme gastro-intestinal.
JP3190340B2 (ja) * 1991-09-24 2001-07-23 アメリカ合衆国 酸化窒素供与体プロドラッグとしての求核試薬−酸化窒素付加物の酸素置換誘導体
US5910316A (en) 1992-08-24 1999-06-08 The United States Of America, As Represented By The Department Of Health And Human Services Use of nitric oxide-releasing agents to treat impotency
US6200558B1 (en) 1993-09-14 2001-03-13 The United States Of America As Represented By The Department Of Health And Human Services Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
US5691423A (en) * 1992-08-24 1997-11-25 The United States Of America As Represented By The Department Of Health And Human Services Polysaccharide-bound nitric oxide-nucleophile adducts
US5525357A (en) * 1992-08-24 1996-06-11 The United States Of America As Represented By The Department Of Health And Human Services Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
US5405919A (en) * 1992-08-24 1995-04-11 The United States Of America As Represented By The Secretary Of Health And Human Services Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions and methods of treating biological disorders
US5714511A (en) * 1995-07-31 1998-02-03 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Selective prevention of organ injury in sepsis and shock using selection release of nitric oxide in vulnerable organs
FR2752380B1 (fr) * 1996-08-14 1998-10-30 Dow Corning Sa Procede de fabrication d'un dispositif a liberation controlee
US6261594B1 (en) 1998-11-25 2001-07-17 The University Of Akron Chitosan-based nitric oxide donor compositions
US6432448B1 (en) 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
US6723342B1 (en) 1999-02-08 2004-04-20 Fmc Corporation Edible coating composition
US6500462B1 (en) 1999-10-29 2002-12-31 Fmc Corporation Edible MCC/PGA coating composition
IL155959A0 (en) 2000-11-28 2003-12-23 Fmc Corp Edible pga (propylene glycol alginate) coating composition
KR100477364B1 (ko) * 2002-07-03 2005-03-22 주식회사 메디켐스 신규한 헬리코박터 파이로리 균 진단용 13ｃ-요소 캅셀 제제
US8679533B2 (en) 2002-07-25 2014-03-25 Pharmacia Corporation Pramipexole once-daily dosage form
UA95993C2 (ru) 2004-08-13 2011-09-26 Бёрингер Ингельхайм Интернациональ Гмбх Композиция пеллеты пролонгированного высвобождения, которая содержит прамипексол или его фармацевтически приемлемую соль, способ ее изготовления и ее применение
MX2007001765A (es) 2004-08-13 2007-04-20 Boehringer Ingelheim Int Formulacion en comprimidos de liberacion extendida que contiene pramipexol o una sal farmaceuticamente aceptable del mismo, metodo para su fabricacion y su uso.
EP1745775B1 (de) * 2005-07-19 2008-05-28 Ethypharm Gastroretentive Zusammensetzungen und Verfahren zur Herstellung
WO2007086078A2 (en) * 2006-01-30 2007-08-02 Panacea Biotec Ltd. Novel pharmaceutical compositions and process of preparation thereof
GB0909680D0 (en) 2009-06-05 2009-07-22 Euro Celtique Sa Dosage form
EP2558132B1 (de) * 2010-04-14 2020-10-14 Mölnlycke Health Care AB Antimikrobielle gele
KR101479388B1 (ko) 2010-05-10 2015-01-05 유로-셀티큐 에스.에이. 활성제 로딩된 과립과 추가의 활성제와의 조합물
JP5671609B2 (ja) 2010-05-10 2015-02-18 ユーロ−セルティーク エス．エイ． ヒドロモルホンおよびナロキソンを含む医薬組成物
MX340188B (es) 2010-05-10 2016-06-30 Euro-Celtique S A * Elaboracion de granulos sin activos y tabletas que comprenden los mismos.
GB201020895D0 (en) 2010-12-09 2011-01-26 Euro Celtique Sa Dosage form
US9814710B2 (en) 2013-11-13 2017-11-14 Euro-Celtique S.A. Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome
KR101599126B1 (ko) 2014-04-01 2016-03-14 주식회사 명성 스크루식 뚜껑 성형장치
US11529310B2 (en) 2020-12-08 2022-12-20 Ruminant Biotech Corp Limited Devices and methods for delivery of substances to animals
WO2023148315A1 (en) * 2022-02-03 2023-08-10 Basf Se Potassium-sodium tartrate as granulating aid

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE791632A (fr) * 1971-11-20 1973-05-21 Schering Ag Supports a base de caoutchouc siliconique pour agents medicamenteux
US3991750A (en) * 1975-04-28 1976-11-16 Syntex Corporation Dromostanolone propionate implant pellet useful for producing weight gains in animals and suppressing estrus in female animals
SE8203953D0 (sv) * 1982-06-24 1982-06-24 Astra Laekemedel Ab Pharmaceutical mixture
CA1331338C (en) * 1987-02-03 1994-08-09 Dow Corning Corporation Aqueous film-forming compositions for controlling the release of active agents and process of making same
FR2610827B1 (fr) * 1987-02-18 1991-09-13 Pf Medicament Comprime de dihydroergotamine (d.h.e.) du type a matrice hydrophile et son procede de fabrication
GB8704755D0 (en) * 1987-02-28 1987-04-01 Dow Corning Ltd Pharmaceutical delivery device

Also Published As

Publication number Publication date
AU639947B2 (en) 1993-08-12
HU906525D0 (en) 1991-04-29
JPH03167116A (ja) 1991-07-19
FR2653337A1 (fr) 1991-04-26
EP0425154B1 (de) 1993-09-15
EP0425154A1 (de) 1991-05-02
CA2027865A1 (en) 1991-04-24
AU6486390A (en) 1991-04-26
DE69003347T2 (de) 1994-02-17
IE903777A1 (en) 1991-04-24
IE66826B1 (en) 1996-02-07
BR9005223A (pt) 1991-09-17
KR910007518A (ko) 1991-05-30
DK0425154T3 (da) 1993-11-01
FI905195A0 (fi) 1990-10-22
ES2044451T3 (es) 1994-01-01
HUT69395A (en) 1995-09-28
FR2653337B1 (fr) 1992-02-07

Similar Documents

Publication Publication Date Title
DE69003347T2 (de) Elemente mit protrahierter Wirkstoffabgabe.
DE59003337D1 (de) Pressling mit retardierter Wirkstofffreisetzung.
DE3880593D1 (de) Arzneizubereitungen mit retardierter wirkstofffreisetzung.
NO904694L (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater.
NO901684D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater.
NO884408L (no) Kontrollerte frigjoeringsformuleringer av tetracyklinforbindelser.
DE69000881T2 (de) 2-propylvaleriansaeure enthaltende arzneizubereitung mit verzoegerter wirkstofffreigabe.
TR24459A (tr) Tasiyici tertibatlarin imal edilmesine mahsus yapi takimi
NO894630L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater.
NO903088L (no) Fremgangsmaate for fremstilling av terapeutisk aktive diazepin-derivater.
NO870173D0 (no) Antiseptisk preparat.
NO890494D0 (no) Begroingshindrende preparat.
NO893616D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tricykliske forbindelser.
NO890155D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive indolpiperidin-forbindelser.
NO892733D0 (no) Fremgangsmaate for fremstilling av syntetiske lungeoverflateaktive preparater omfattende lipider og polypeptider.
NO900697D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive acetamid-derivater.
NO891723D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO895220L (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzenderivater.
NO894423D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive propanolaminer.
NO900972D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater.
NO892871D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO900942D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive azacyklooktadien-derivater.
NO890724D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetraazaacenaftylen-derivater.
NO890519D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive propanon-derivater.
NO882234L (no) Fremgangsmaate for fremstilling av oeredraapepreparat.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee